Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris D Heifets

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Nature|October 7, 2021
5-HT modulation of a medial septal circuit tunes social memory stabilityXiaoting Wu, Wade Morishita, Kevin T Beier, et al.
Pain Management|April 16, 2026
Protocol and pilot results for a double-blind randomized placebo-controlled trial of ketamine under propofol sedation for chronic pain and depressionTheresa R Lii, Pilleriin Sikka, Ben Deverett, et al.
Journal of Affective Disorders|January 14, 2022
A retrospective analysis of ketamine intravenous therapy for depression in real-world care settingsL Alison McInnes, Jimmy J Qian, Rishab S Gargeya, et al.
Journal of Neurochemistry|October 3, 2002
Regulation of regulators of G protein signaling mRNA expression in rat brain by acute and chronic electroconvulsive seizuresStephen J Gold, Boris D Heifets, Cindy M Pudiak, et al.
A&A Practice|May 1, 2018
Case Report of an Awake Craniotomy in a Patient With Eisenmenger SyndromeBoris D Heifets, Erin Crawford, Ethan Jackson, et al.
The American Journal of Psychiatry|May 2, 2019
Rigorous Translational Models Are Key to Studying Ketamine's Antidepressant Mechanism: Response to Wang and KaplinBoris D Heifets, Nolan R Williams, Christine Blasey, et al.
Psychopharmacology|April 1, 2022
Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trialsJacob S Aday, Boris D Heifets, Steven D Pratscher, et al.
The American Journal of Psychiatry|March 2, 2019
Interpreting Ketamine's Opioid Receptor Dependent Effect: Response to SanacoraBoris D Heifets, Nolan R Williams, Christine Blasey, et al.
The American Journal of Psychiatry|March 2, 2019
Target Population, Dose, and Timing Considerations for Understanding Naltrexone's Subjective Effect: Response to AmiazBoris D Heifets, Nolan R Williams, Christine Blasey, et al.
Neuron|June 8, 2007
Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alphaVivien Chevaleyre, Boris D Heifets, Pascal S Kaeser, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Nature|October 7, 2021
5-HT modulation of a medial septal circuit tunes social memory stabilityXiaoting Wu, Wade Morishita, Kevin T Beier, et al.
Pain Management|April 16, 2026
Protocol and pilot results for a double-blind randomized placebo-controlled trial of ketamine under propofol sedation for chronic pain and depressionTheresa R Lii, Pilleriin Sikka, Ben Deverett, et al.
Journal of Affective Disorders|January 14, 2022
A retrospective analysis of ketamine intravenous therapy for depression in real-world care settingsL Alison McInnes, Jimmy J Qian, Rishab S Gargeya, et al.
Journal of Neurochemistry|October 3, 2002
Regulation of regulators of G protein signaling mRNA expression in rat brain by acute and chronic electroconvulsive seizuresStephen J Gold, Boris D Heifets, Cindy M Pudiak, et al.
A&A Practice|May 1, 2018
Case Report of an Awake Craniotomy in a Patient With Eisenmenger SyndromeBoris D Heifets, Erin Crawford, Ethan Jackson, et al.
The American Journal of Psychiatry|May 2, 2019
Rigorous Translational Models Are Key to Studying Ketamine's Antidepressant Mechanism: Response to Wang and KaplinBoris D Heifets, Nolan R Williams, Christine Blasey, et al.
Psychopharmacology|April 1, 2022
Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trialsJacob S Aday, Boris D Heifets, Steven D Pratscher, et al.
The American Journal of Psychiatry|March 2, 2019
Interpreting Ketamine's Opioid Receptor Dependent Effect: Response to SanacoraBoris D Heifets, Nolan R Williams, Christine Blasey, et al.
The American Journal of Psychiatry|March 2, 2019
Target Population, Dose, and Timing Considerations for Understanding Naltrexone's Subjective Effect: Response to AmiazBoris D Heifets, Nolan R Williams, Christine Blasey, et al.
Neuron|June 8, 2007
Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alphaVivien Chevaleyre, Boris D Heifets, Pascal S Kaeser, et al.
Pageof 8